Glucosamine and Chondroitin May Lower the Risk of Colorectal Cancer
Glucosamine and chondroitin supplements have anti-inflammatory properties and are best known for their joint health benefits. A recent study suggests that they may also lower the risk of developing colorectal cancer by 45%.
The researchers examined data from the VITamins And Lifestyle (VITAL) study, which included 75,137 Washington residents between the ages of 50 and 76. The respondents were placed into one of three groups based on their weekly glucosamine and chondroitin intake during a 10 year period:
1. high use – four days or more per week;
2. low use – fewer than four days per week;
Participants in the high use group had a 45% reduced risk of developing colorectal cancer when compared to users in the non-use group.
Researchers from the Fred Hutchinson Cancer Research Center in Washington conducted the study. It was published in the June 2013 issue of Cancer Causes Control.
Glucosamine is produced naturally in the body and helps with joint function. Glucosamine supplements have been found to help with osteoarthritis, reducing joint pain and improving joint function.
Chondroitin is found in and around the cells of cartilage, and provides cartilage with strength and resilience. Previous research has found that chondroitin may help ease the pain of arthritis and osteoporosis, lower cholesterol and possibly help with ulcerative colitis and Crohn’s disease.